Mark S. Blumenkranz, CEO & Chairman

By FLG Partners

“I’ve had the fortunate opportunity  to work closely with Mark Murray of FLG Partners in a series of  four  successful venture backed -backed companies in Silicon Valley  over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis)….Read More

Apttus, Inc.

By FLG Partners

Ciphergen Biosystems, Inc.

By FLG Partners

Following the departures of the CFO and the Controller, FLG’s Jim Pardee was engaged as Interim CFO while the company recruited a permanent CFO. With the departure of additional personnel, the initial focus was on rebuilding the accounting team while at the same time focusing on cash management and expense…Read More

Pieter de Villiers, CEO and Co-Founder

By FLG Partners

“As a condition to closing our US venture round led by Sequoia Capital, we needed to complete a complex corporate restructuring to flip our foreign domiciled company to become a US based HQ (we had been operating as a South African based entity for several years).  We needed a CFO…Read More